slot gacor slot gacor hari ini slot gacor 2025 demo slot pg slot gacor slot gacor
Correlation between Degree of Leprosy Disability and Serum IL-6 Levels in Patients with Leprosy Reactions: An Observational Study at the Donorojo Jepara Leprosy Hospital Center | Putri | Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal) skip to main content

Correlation between Degree of Leprosy Disability and Serum IL-6 Levels in Patients with Leprosy Reactions: An Observational Study at the Donorojo Jepara Leprosy Hospital Center

*Syifa Nurisma Putri  -  Department of Biomedicine, Faculty of Medicine, Diponegoro University, Jl. Prof. Sudarto, SH, Tembalang, Semarang, Indonesia 50275, Indonesia
Farmaditya Eka Putra Mundhofir orcid scopus  -  Department of Histology, Diponegoro University, Jl. Prof. Sudarto, SH, Tembalang, Semarang, Indonesia 50275, Indonesia
Renni Yuniati orcid scopus  -  Department of Dermatology and Venereology, Diponegoro University, Jl. Prof. Sudarto, SH, Tembalang, Semarang, Indonesia 50275, Indonesia
Noor Wijayahadi scopus  -  Department of Pharmacology, Diponegoro University, Jl. Prof. Sudarto, SH, Tembalang, Semarang, Indonesia 50275, Indonesia
Yora Nindita orcid scopus  -  Department of Pharmacology, Diponegoro University, Jl. Prof. Sudarto, SH, Tembalang, Semarang, Indonesia 50275, Indonesia

Citation Format:
Abstract

Background: Leprosy is an infectious disease caused by Mycobacterium leprae bacteria which is still the focus of a global problem and causes disability in patients. The degree of disability in leprosy is assessed as mild and severe as a result of the inflammatory process. This study aims to determine the relationship between the degree of disability in leprosy and IL-6 serum levels as an inflammatory biomarker in leprosy patients. Methods: A Cross-sectional observational analytical study on leprosy patients aged 20-60 years, not pregnant, and undergoing treatment at Donorojo Jepara Hospital from March to April 2024. Serum IL-6 levels were analyzed using the ELISA method and tested for correlation with the degree of disability leprosy. Results: Statistical analysis of Spearman's correlation rank test shows a p value = 0.279 and the results of the line pattern on the Scatter dot graph are not linear. Conclusion: There is no correlation between serum IL-6 levels and the degree of disability in leprosy patients at Donorojo Jepara Hospital.

Keywords: Degree of Disability in Leprosy, Leprosy, Serum IL-6

Fulltext View|Download
Keywords: Degree of Disability in Leprosy; Leprosy; Serum IL-6

Article Metrics:

  1. WHO. Global leprosy update, 2018 moving towards a leprosy-free world. World Health Organization [Internet]. 2019 [cited 2023 Jul 27];94:389–412. Available from: http://www.who.int/wer
  2. WHO. Towards zero leprosy: global leprosy (‎Hansen's disease)‎ strategy 2021–2030 [Internet]. WHO, editor. 2021 [cited 2023 Sep 13]. Available from: https://apps.who.int/iris/handle/10665/340774
  3. Putri AI, de Sabbata K, Agusni RI, Alinda MD, Darlong J, de Barros B, et al. Understanding leprosy reactions and the impact on the lives of people affected: An exploration in two leprosy endemic countries. PLoS Negl Trop Dis. 2022 Jun 1;16(6)
  4. Association of Indonesian Dermatology and Venereology Specialists. Clinical Practice Guide for Dermatology and Venereology Specialists in Indonesia. Perdoski. 2017;80–100
  5. Pratama N, Luh Made Mas Rusyati, Prima Sanjiwani Saraswati Sudarsa, IGAA Dwi Karmila, NLP Ratih Vibriyanti Karna. Borderline Lepromatous Leprosy with Severe Erythema Nodosum Leprosum: A Case Report. Periodicals of Skin and Venereology Health Sciences. 2022 Nov 30;34(3):210–6
  6. WHO. Leprosy/Hansen Disease: Management of reactions and prevention of disabilities technical guidance. 2020; Available from: http://apps.who.int/bookorders
  7. Walker SL. Leprosy reactions. In: Scollard DM, Gillis TP, editors. The International Textbook of Leprosy [Internet]. London: London School of Hygiene and Tropical Medicine; 2020 [cited 2023 Jul 25]. p. 1–30. Available from: https://internationaltextbookofleprosy.org/authors/walker
  8. Pinheiro RO, Schmitz V, Silva BJA, Dias AA, de Souza BJ, de Mattos Barbosa MG et al. Innate immune response in leprosy. Front Immunol. 2018 Mar 28;9:518
  9. Luo Y, Kiriya M, Tanigawa K, Kawashima A, Nakamura Y, Ishii N, et al. Host-Related Laboratory Parameters for Leprosy Reactions. Front Med (Lausanne) [Internet]. 2021;8. Available from: https://www.frontiersin.org/articles/10.3389/fmed.2021.694376
  10. Saini C, Siddiqui A, Ramesh V, Nath I. Leprosy Reactions Show Increased Th17 Cell Activity and Reduced FOXP3+ Tregs with Concomitant Decrease in TGF-β and Increase in IL-6. PLoS Negl Trop Dis. 2016 Apr 1;10(4):1–21
  11. Yuniati R, Agusni I. IL-6 Levels in Leprosy Patients with Reversal Reactions. Pakistan Journal of Health & Medical Sciences [Internet]. 2018 [cited 2023 Sep 13];12(3):1340-2. Available from: https://pjmhsonline.com/2018/july_sep/pdf/1340.pdf
  12. Yang J, Li X, Sun Y, Zhang L, Jin G, Li G, et al. Global epidemiology of leprosy from 2010 to 2020: A systematic review and meta-analysis of the proportion of sex, type, grade 2 deformity and age. Vol. 116, Pathogens and Global Health. Taylor and Francis Ltd.; 2022. p. 467–76
  13. N. S NA, Muniroh M, Kusumaningrum N, PM FE, Yuniati R. Clitoria ternatea L. Extract as Adjuvant Therapy on Reducing IL-6 Levels in Reversal Reaction. Biosaintifika: Journal of Biology & Biology Education. 2023 Apr 30;15(1)
  14. Sarode G, Sarode S, Anand R, Patil S, Jafer M, Baeshen H, et al. Epidemiological aspects of leprosy. Vol. 66, Disease-a-Month. Mosby Inc.; 2020
  15. Nazli PAN, Lubis SR, Khairina. Correlation between the stress scale and cortisol levels in leprosy patients. Bali Medical Journal. 2021;10(1):500-4
  16. Pinsornsak P, Niempoog S. The efficacy of Curcuma Longa L. extract as an adjuvant therapy in primary knee osteoarthritis: a randomized control trial. J Med Assoc Thai. 2012 Jan;95(Suppl-1):S51-8
  17. Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology. Philadelphia: Elsevier Inc. 2018;9th ed
  18. Peng Y, Ao M, Dong B, Jiang Y, Yu L, Chen Z, et al. Anti-inflammatory effects of curcumin in inflammatory diseases: Status, limitations and countermeasures. Vol. 15, Drug Design, Development and Therapy. Dove Medical Press Ltd; 2021. p. 4503–25
  19. Saini C, Srivastava RK, Tarique M, Kurra S, Khanna N, Ramesh V, et al. Elevated IL-6R on CD4+ T cells promotes IL-6 driven Th17 cell responses in patients with T1R leprosy reactions. Sci Rep. 2020 Dec 1;10(1)
  20. Angst DBM, Pinheiro RO, Vieira JS da S, Cobas RA, Hacker M de AVB, Pitta IJR, et al. Cytokine Levels in Neural Pain in Leprosy. Front Immunol. 2020 Jan 24;11
  21. Bäckryd E. Pain in the blood? Envisioning mechanism-based diagnoses and biomarkers in clinical pain medicine. Diagnostics. 2015;5(1):84–95
  22. Andrade P, Hoogland G, Garcia MA, Steinbusch HW, Daemen MA, Visser-Vandewalle V. Elevated IL-1b and IL-6 levels in lumbar herniated discs in patients with sciatic pain. European Spine Journal. 2013 Apr;22(4):714–20
  23. Ren T, Cidlowski JA. Antiinflammatory Action of Glucocorticoids-New Mechanisms for Old Drugs. New England Journal of Medicine [Internet]. 2005;353:1711-23. Available from: www.nejm.org

Last update:

No citation recorded.

Last update:

No citation recorded.